首页>
外国专利>
Biomarkers to predict TACE treatment efficacy for hepatocellular carcinoma
Biomarkers to predict TACE treatment efficacy for hepatocellular carcinoma
展开▼
机译：预测TACE治疗肝癌疗效的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to the diagnosis of liver cancer, and more particularly to a biomarker for the diagnosis of liver cancer chemoembolization (TACE) prognosis. The biomarkers according to the present invention utilize MRM technology, which can predict the prognosis of chemoembolization with high accuracy and sensitivity and a large number of screenings in a short time.;
展开▼
